rais dupont fve updat pre-merg
page full analyst note feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data feb
rate updat feb
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
dupont de nemour world-renown chemic compani
histori span year ever-evolv portfolio
current iter dupont specialti chemic compani
creat dowdupont merger subsequ
separ compani four distinct busi line
gener roughli one fourth profit sell product differ
end market sale auto industri
end-market make dupont fairli diversifi
forecast consolid revenu grow slightli global
dupont produc noteworthi high-profit product
year safeti construct segment invent
product lycra kevlar wide applic
textil safeti equip tyvek broadli use
product develop innov compani solid
record innov think abl replac earn
older product fall favor leapfrog
new technolog patent expir
dupont well posit captur profit growth secular
trend come year transport advanc
polym segment dupont benefit automak
replac small metal piec lighter plastic trend
continu automak move toward lightweight
vehicl electron imag segment dupont
benefit continu growth semiconductor rise
interconnect devic requir electron
smartphon comput automobil
consum applianc dupont also expos electrif
vehicl compani gener revenu per
vehicl electr vehicl versu intern combust engin
decemb dupont announc transact merg
entir nutrit bioscienc portfolio intern flavor
fragranc tax-effici transact dupont
sharehold receiv combin compani
expect transact close earli
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note contain pro forma histor result dupont financi
stand-alone entiti actual financi may differ
dupont diversifi global specialti chemic compani creat
dowdupont merger subsequ separ portfolio
includ chemic downstream product serv automot
electron commun construct safeti protect
industri dupont benefit abil produc patent specialti
chemic command price power noteworthi product includ
kevlar tyvek nomex tend wide rang applic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rais dupont fve updat pre-merg
updat intern flavor fragranc
model follow compani fourth-quart result
assum valuat current oper increas
due time valu money effect result make
propos merger dupont nutrit
bioscienc busi value-accret
dupont sharehold expens sharehold
dupont sharehold combin entiti
give dupont sharehold upsid equiti valu
updat dupont model reflect higher
valu rais dupont fair valu estim per
share calcul valu b-iff
combin worth per share assum
dupont fair valu dupont sharehold
fair valu previous continu expect
transact close earli narrow-moat rate
dupont unchang
view dupont share materi under-valued current
trade territori share trade well
per share fair valu estim share
transfer dupont sharehold part
transact clear view b-iff merger
value-accret dupont sharehold howev today
close price around per share valu dupont
per share exclud per share valuat
 b-iff deal also ascrib valu
asset remain dupont portfolio follow
dupont share like reflect toxic chemicals-rel
risk
resolv dupont current su
rework indemnif agreement two
lawsuit dupont
compani pay dupont
pfas-rel liabil cost lawsuit like
resolv could drive ralli dupont share
view dupont current share price opportun
sharehold pick high qualiti name signific
discount dupont share trade bear-cas
fair valu estim assum dupont pay
hefti settlement billion toxic chemicals-rel
base case assum dupont pay billion total
relat toxic chemic includ million
settl lawsuit settlement
magnitud would sit total dupont agre pay
two compani resolv disput
remain million come upper end
dupont state liabil rang toxic chemic lawsuit
environment cleanup expens
fair valu estim per share base
discount cash flow model weight averag cost
capit dupont stage ii growth
rate reflect dupont price power
develop new patent product compani
exposur higher grow end-market
fair valu estim assum deal merg
nutrit bioscienc busi intern
flavor fragranc close dupont sharehold
slate receiv combin compani
dupont would receiv billion dividend howev
assum newli combin compani achiev
roughli project million annual ebitda
synergi assum manag abl
realiz major cost-rel synergi
skeptic propos revenu synergi
dupont sharehold valu merger
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
estim depend compani abil continu
develop innov product dispar
busi line uncertain construct
three scenario -- base case describ valuat
section bull case bear case -- highlight rang
potenti outcom
bull case assum strong stabl global
market also assum faster growth semiconductor
connect technolog scenario dupont
success introduc innov high-margin product
electron materi segment dupont
safeti protect segment carri
mantl kevlar tyvek other transport
advanc polym segment benefit increas
market share per vehicl automot lightweight
electrif take hold bull case also assum
merger transact close abl achiev
full synergi bull-cas fair valu estim per
bear case assum protract slowdown
global econom recoveri weigh demand also
assum lack new product electron
materi busi slower growth semiconductor
connect technolog addit assum
slowdown automot lightweight electrif
weigh profit transport advanc
polym busi scenario dupont may forc
cut price stem share loss weigh margin
scenario assum dupont must pay
billion settl lawsuit half amount chemour
request billion base case
assum dupont must pay addit billion
million base case assumpt help fund
chemours-rel toxic chemic lawsuit environment
cleanup expens total nearli billion bear
case also assum health nutrit transact
roughli per share fair valu estim
forecast low- mid-single-digit compound annual
organ sale growth next five year led gain
firm attract advanc materi electron
transport busi expect outpac
global growth dupont continu develop new
product forecast oper margin expand slightli
stay rang five-year explicit
base case also assum dupont pay total
billion toxic chemicals-rel lawsuit expens
assum dupont pay million settl lawsuit
remain million come
addit toxic chemic lawsuit environment
cleanup expens upper end dupont state
liabil rang around half amount alreadi accru
balanc line manag project
addit liabil might aris
uncertainti rate dupont medium fair valu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
close achiev synergi unabl achiev
much growth bear case fair valu estim per
award dupont narrow econom moat rate
intang asset base compani patent portfolio
specialti product compani success develop
innov materi creat group patent
product enjoy premium posit market
exampl dupont advanc materi busi
kevlar proprietari product becom materi
choic militari law enforc safeti
protect similarli nomex materi choic
firefight due heat resist properti tyvek
market-lead housewrap materi product
other dupont develop multipl version end market
product kevlar nomex use
consum industri applic result dupont
continu earn excess return specialti product
even patent expir gener develop
life cycl item use patent
product kevlar bulletproof vest extend
well beyond patent expir new use
emerg well
compani health nutrit busi benefit
switch cost nutrit bioscienc segment
hous health nutrit busi key
product includ microcrystallin cellulos mcc
use bind dri tablet roughli half prescript
written year market function
nonact ingredi control releas polym
although signific drug patent expir
come year expect busi continu
hold high market share due high switch cost
pharmaceut product shift patent gener drug
produc look minim risk simplifi regulatori
process use ingredi chang
drug includ binder ingredi
origin product difficult feat consid high
standard qualiti consist requir
food drug administr failur demonstr
equival would mean gener product
pass regulatori approv gener drug produc
tend stick binder function nonact
ingredi alreadi use patent product
think dupont proven abil
margin elev patent expir competitor develop
portfolio demand elev margin enjoy higher
barrier entri stickier custom relationship
confid dupont outearn cost capit
least next year
moat trend dupont stabl see offset
trend compani record develop innov
higher-margin product materi dupont
advanc materi electron busi
allow compani continu develop new
product would strengthen firm
competit advantag howev patent expir
greatli reduc profit product older
specialti chemic often fall favor
replac newer better product result dupont must
develop new product order maintain healthi profit
margin compani competit advantag
patent specialti chemic remain intact
materi strengthen weaken
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
odupont specialti chemic busi among
best world develop product kevlar
tyvek command price power gener
oth electron
well
posit grow profit result grow
demand semiconductor increas connect
internet thing technolog
oth dowdupont merger subsequ separ
three compani creat valu sharehold
cut cost excess manag target
improv profit margin next
odupont pfas-rel liabil grow risk
compani liabl portion total
pfas-rel cleanup litig cost could
rise materi dupont unabl defend
lawsuit
odupont electron advanc materi
busi expos china risk
affect prolong trade conflict
china
odupont underinvest rel peer
could limit abil gener new product
gain market share long term
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
dowdupont spun three compani good financi
shape total net debt dupont roughli billion
dec net debt/trail oper
ebitda around time although
manag long-term goal time think
level still manag merg nutrit
bioscienc busi
flavor
fragranc dupont receiv billion payment
merg busi deal close manag
use proce pay debt think
remain proce like use repurchas
share dupont plan pay least million dividend
annual grow net incom manag target
pay-out ratio dividend forecast dupont
gener signific free cash flow allow
firm meet financi oblig remain
cash flow support dividend
dupont face stiff competit across chemic market
firm oper mani highli cyclic end market
residenti construct
electron could see prolong slowdown demand
end market addit guarante
dupont invest research develop
new specialti chemic product bear fruit dupont
unabl develop new product replac formula
roll patent develop new use product patent
expir new product fail gener
increment demand growth end user
compani abil charg premium product would
deterior major sale outsid
 compani expos fluctuat foreign
currenc like chemic produc compani
continu face possibl environment
health-rel remedi cost asbesto
liabil dupont risk litig relat pfa
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
pfas-rel
relat toxic chemic lawsuit environment
face bulk risk relat lawsuit
spun dupont agreement
howev su dupont goal
set cap liabil would pay
even dupont win lawsuit dupont like
fund part settlement environment
cleanup expens chemour becom unabl pay
dupont liabil dupont would like hook
settlement cleanup expens ultim dupont
remain risk long face lawsuit
liabil relat toxic chemic still part
dupont
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
capit research manag compani
share
fund
share
fund
doyl join dupont presid
protect technolog busi merger
close time dupont
singl compani doyl specialti product
compani dupont dowdupont
merger subsequ separ dupont emerg
specialti chemic compani
chemic exposur favor compani
focus develop new patent product
sustain price power
manag first major move divest nutrit
bioscienc busi merger transact
flavor fragranc think dupont
negoti attract price receiv multipl
time ebitda synergi
manag target invest roughli
sale research develop think
enough develop new product rang invest
wide-moat peer honeywel
novozym result think dupont like
abl catch competitor compani
alreadi hold market-lead posit
manag incent base metric
includ return invest capit favor
return invest capit metric think incentiv
manag invest value-ad area busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rais dupont fve updat pre-merg
updat intern flavor fragranc
model follow compani fourth-quart result
assum valuat current oper increas
due time valu money effect result make
propos merger dupont nutrit
bioscienc busi value-accret
dupont sharehold expens sharehold
dupont sharehold combin entiti
give dupont sharehold upsid equiti valu
updat dupont model reflect higher
valu rais dupont fair valu estim per
share calcul valu b-iff
combin worth per share assum
dupont fair valu dupont sharehold
fair valu previous continu expect
transact close earli narrow-moat rate
dupont unchang
view dupont share materi under-valued current
trade territori share trade well
per share fair valu estim share
transfer dupont sharehold part
transact clear view b-iff merger
value-accret dupont sharehold howev today
close price around per share valu dupont
per share exclud per share valuat
 b-iff deal also ascrib valu
asset remain dupont portfolio follow
dupont share like reflect toxic chemicals-rel
risk
resolv dupont current su
lawsuit dupont
rework indemnif agreement two
compani pay dupont
pfas-rel liabil cost lawsuit like
resolv could drive ralli dupont share
view dupont current share price opportun
sharehold pick high qualiti name signific
discount dupont share trade bear-cas
fair valu estim assum dupont pay
hefti settlement billion toxic chemicals-rel
base case assum dupont pay billion total
relat toxic chemic includ million
settl lawsuit settlement
magnitud would sit total dupont agre pay
two compani resolv disput
remain million come upper end
dupont state liabil rang toxic chemic lawsuit
environment cleanup expens
dupont soft guidanc send share
dupont fourth-quart result steadi compar
first three quarter year higher price across
segment off-set lower volum
dupont face declin demand mani end market
led companywid declin sale profit year
year manag guidanc cite flat adjust
ep versu despit continu cost reduct
expect forecast return growth
updat model reflect lower near-term
profit lawsuit settlement reduc
dupont fair valu estim per share
narrow moat rate unchang
market react neg earn releas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
send share day share
neg near-term sentiment long-term outlook
unchang view dupont share materi
under-valued current trade territori
see two near-term catalyst could boost stock
first dupont current su
rework indemnif agreement two
compani pay dupont
pfas-rel liabil cost lawsuit like
resolv could support higher share price
dupont receiv favor outcom base case
assum dupont pay million settl
lawsuit slightli total dupont agre
pay two compani resolv disput
second think two dupont busi could return
growth nutrit bioscienc dupont
well posit captur grow plant protein demand
forecast continu demand growth hous
water treatment demand benefit
safeti construct busi cours year
propos nutrit bioscienc merger
look attract dupont rais fve dec
dec dupont announc would merg
nutrit bioscienc busi intern
flavor fragranc term appear slightli
favor dupont sharehold updat
valuat model account deal rais
fair valu estim dupont per share
narrow moat rate unchang fair valu
estim assum probabl deal
close see littl overlap two portfolio
well signific cut propos synergi target
current price view dupont significantli
under-valued stock trade territori
term deal dupont sharehold
receiv equiti stake merg compani
dupont receiv billion dividend pay-out
compani transact close base
valuat dupont effect receiv time
presynergi multipl view attract
although initi thought dupont asset might
command even higher multipl amid report bid
war kerri group announc term still
repres good price base valuat
think overpay dupont asset
benefit dupont sharehold expens
although consid deal modestli value-accret
dupont skeptic new compani abl
achiev revenu cost-cut target
cost-cut effort appear reason
elimin back-offic expens
manufactur effici skeptic revenu
synergi forecast manag
abl achiev total project ebitda
synergi target assum full synergi
realiz dupont fair valu would rise addit
nutrit bioscienc divestitur first major
move new dupont creat june
spin chemic dupont
although divestitur could come saw littl
oper overlap nutrit health busi
remain three segment think
decis divest nutrit health busi make
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
 flavor fragranc share lower potenti
dec bloomberg report rumor
flavor fragranc explor combin
dupont nutrit busi news
specul point dupont valuat
model unchang maintain per share fair
valu estim wide-moat rate well
per share fair valu estim narrow-moat rate
dupont
reportedli kerri group express
interest dupont nutrit asset overal size
busi play high qualiti underli
asset exhibit clear trace switch cost
intang asset combin potenti bid
war like set lofti price tag
hous dupont nutrit asset well
bidder asset would spun exist investor
tax-effici transact remain seen
portion dupont nutrit bioscienc segment
would ultim involv deal howev given
trade multipl competitor surmis
segment whole would command multipl safe
time ebitda rang time trail ebitda
would suggest segment valuat rang
billion howev estim price rang
nutrit busi alon would roughli two third
dupont nutrit busi overlap exist
busi line also offer new adjac
howev share trade nearli lower
news still digest acquisit frutarom
consumm octob news potenti
much larger deal dupont come surpris
investor caution reflect today downward share price
movement understand on-going integr
frutarom far seamless
maintain fve dupont post decent third-
despit continu weak demand mani dupont end
automot electron
industri compani still post decent third-quart
result otherwis oper ebitda year
year billion lower volum currenc
headwind partial off-set higher price
earn releas manag narrow adjust
ep guidanc rang previou
rang outlook larg unchang
maintain per share fair valu estim
dupont narrow moat rate base compani
price power specialti chemic remain intact
current price view dupont under-valued
share trade firmli territori think market
take overli pessimist view dupont futur
growth prospect environment liabil share
trade slightli per share bear-cas fair valu
estim like mani specialti chemic peer dupont
face weak demand environ led fall
volum yet dupont abil rais price allow
compani partial off-set declin
think compani abl grow oper ebitda
demand begin stabil point
near-term catalyst share
comparison bear case impli revenu growth
declin oper ebitda next sever year
bear case also assum dupont pay billion
legal liabil relat toxic chemic lawsuit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
environment liabil result view current price
great opportun long-term investor good-
qualiti compani suitabl margin safeti
inform electr vehicl outlook see
report titl electr vehicl one
auto sold publish oct
electr vehicl sale one auto
ev reach function pariti oct
batteri electr vehicl account one
everi five auto sold although ev global
auto sale growth still nascent howev
increas adopt linear ev
reach cost pariti intern combust engin
perform pariti well featur compar
drive rang recharg time result ev
longer inferior product versu
charg infrastructur serv region wild card
either spur limit adopt
improv cost rang charg time
roll global given size scale major
automak batteri produc china europ
necessari charg infrastructur support mass
market ev adopt
infrastructur place part countri
result forecast second half next decad
see rapid ev adopt howev also
decad hybrid partial electr vehicl
reach new auto sale inde half
new car sold ev hybrid
across ev suppli chain ancillari industri like
auto supplier well posit across hybrid
ev platform low-cost lithium produc alreadi
product util oper ev-friendli region
top pick invest grow ev adopt includ
ford panason sqm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
